High-dose tissue plasminogen activator, topical nitroglycerin, and heparin for severe ischemic injury in a neonate

Clin Pediatr (Phila). 2012 Nov;51(11):1095-8. doi: 10.1177/0009922811423312. Epub 2011 Oct 12.

Authors

Olugbenga Akingbola¹, Dinesh Singh, Rodney Steiner, Edwin Frieberg, Matei Petrescu

Affiliation

¹ Department of Pediatrics, Tulane Hospital for Children, New Orleans, LA 70112, USA. oakingbo@tulane.edu

PMID: 21997143
DOI: 10.1177/0009922811423312

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Cutaneous
Catheterization / adverse effects
Drug Therapy, Combination
Femoral Artery / injuries
Fibrinolytic Agents / administration & dosage*
Follow-Up Studies
Heparin / administration & dosage*
Humans
Infant
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / drug therapy
Infusions, Intravenous
Intensive Care Units, Pediatric
Ischemia / drug therapy*
Ischemia / etiology
Ischemia / pathology
Leg / blood supply*
Male
Nitroglycerin / administration & dosage*
Severity of Illness Index
Thrombosis / complications
Thrombosis / drug therapy
Thrombosis / etiology
Tissue Plasminogen Activator / administration & dosage*
Toes / blood supply
Treatment Outcome
Vasodilator Agents / administration & dosage*

Substances

Fibrinolytic Agents
Vasodilator Agents
Heparin
Tissue Plasminogen Activator
Nitroglycerin